Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Loss of cystic fibrosis transmembrane conductance regulator function produces abnormalities in tracheal development in neonatal pigs and young children
Some individuals may experience temporary effects such as mild nausea or digestive changes, which often diminish over time
Our commitment to transparency means you can trust that youre getting a product free from hidden ingredients
It helps identify legitimate providers but does not measure clinical outcomes or personalization depth relative to individual genetics or metabolic status
2018 May 1;622-623:1317-1326
doses selected for the global Phase 3 pivotal program of GH001 in TRD GH001-HV-109 US IND-opening study enrolment completed Cash, cash equivalents and marketable securities of $267.3 million as of March 31, 2026 Net cash proceeds of an additional $111.2 million from underwritten offering received in April 2026 DUBLIN, May 14, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in depression, today reported financial results for the quarter ended March 31, 2026, and provided a business update
US$ 25.52
US$ 23.17
US$ 29.17
US$ 29.53
US$ 26.31
US$ 24.02
US$ 26.94
US$ 22.26
